Biogen forecast 2025 profit below last year's levels and Wall Street expectations on Wednesday, hurt by a strong dollar and ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

Getting at least 30 minutes of daily summer sun in the first year of life may mean a lower relapse risk for children who are diagnosed with multiple sclerosis (MS) later, according to a study ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

Getting at least 30 minutes of daily summer sun in the first year of life may mean a lower relapse risk for children who are diagnosed with multiple sclerosis (MS) later, according to a study ...

Lina Nielsen, 28, was diagnosed with MS aged 17 and initially believed that her athletics dreams were over due to her lack of ...

Biogen shares fell, after the biotechnology company forecast lower-than-expected revenue and profit for this year, saying multiple-sclerosis drug sales will decline further and will only be partially ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Kraft Heinz ( KHC) is close to a 52-week low after it reported a 4.6% decline in sales during Q4. Organic sales fell -3.1% ...

Selma Blair opened up about her experience as a single parent living with multiple sclerosis. The 'Legally Blonde' actress, ...

Actor and advocate Selma Blair joins TODAY to discuss her advocacy work for people with multiple sclerosis after sharing her ...

Royalty Pharma is giving Biogen $250 million for its lupus treatment litifilimab, which is currently in Phase 3 development ...